Sarepta Therapeutics (SRPT) Accounts Payables (2010 - 2026)
Sarepta Therapeutics' quarterly Accounts Payables came in at $70.4 million in Q1 2026, down 54.92% year-on-year from $156.1 million in Q1 2025, and down 74.94% quarter-over-quarter from $280.8 million in Q4 2025.
Sarepta Therapeutics has reported Accounts Payables for 17 years, with the latest figure at $70.4 million in Q1 2026.
- For the quarter ending Q1 2026, Accounts Payables fell 54.92% year-over-year to $70.4 million; the trailing twelve-month figure through Mar 2026 stood at $70.4 million (down 54.92% YoY), and the FY2025 full-year result was $280.8 million, up 30.96% from the prior year.
- Accounts Payables for Q1 2026 stood at $70.4 million, down from $280.8 million in the prior quarter.
- The five-year high for Accounts Payables was $280.8 million in Q4 2025, with the low at $54.0 million in Q1 2022.
- Average Accounts Payables over 5 years is $121.4 million, with a median of $107.4 million recorded in 2024.
- Year-over-year, Accounts Payables jumped 168.24% in 2022 and sank 54.92% in 2026.
- Tracing SRPT's Accounts Payables over 5 years: stood at $95.9 million in 2022, then jumped by 72.01% to $164.9 million in 2023, then surged by 30.03% to $214.4 million in 2024, then jumped by 30.96% to $280.8 million in 2025, then plunged by 74.94% to $70.4 million in 2026.
- The last three Accounts Payables figures came in at $70.4 million (Q1 2026), $280.8 million (Q4 2025), and $94.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.05 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 83.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 10.62 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 8.64 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 489.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.03 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 126.63 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn | 70.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 70.38 Mn |
| Dec 31, 2025 | 280.84 Mn |
| Sep 30, 2025 | 94.02 Mn |
| Jun 30, 2025 | 136.70 Mn |
| Mar 31, 2025 | 156.11 Mn |
| Dec 31, 2024 | 214.44 Mn |
| Sep 30, 2024 | 118.77 Mn |
| Jun 30, 2024 | 107.42 Mn |
| Mar 31, 2024 | 91.54 Mn |
| Dec 31, 2023 | 164.92 Mn |
| Sep 30, 2023 | 87.95 Mn |
| Jun 30, 2023 | 109.80 Mn |
| Mar 31, 2023 | 106.71 Mn |
| Dec 31, 2022 | 95.88 Mn |
| Sep 30, 2022 | 118.46 Mn |
| Jun 30, 2022 | 56.21 Mn |
| Mar 31, 2022 | 54.01 Mn |
| Dec 31, 2021 | 76.74 Mn |
| Sep 30, 2021 | 44.16 Mn |
| Jun 30, 2021 | 76.68 Mn |
| Mar 31, 2021 | 76.65 Mn |
| Dec 31, 2020 | 111.09 Mn |
| Sep 30, 2020 | 74.53 Mn |
| Jun 30, 2020 | 91.66 Mn |
| Mar 31, 2020 | 26.60 Mn |
| Dec 31, 2019 | 68.09 Mn |
| Sep 30, 2019 | 81.95 Mn |
| Jun 30, 2019 | 44.05 Mn |
| Mar 31, 2019 | 26.50 Mn |
| Dec 31, 2018 | 33.83 Mn |
| Sep 30, 2018 | 20.41 Mn |
| Jun 30, 2018 | 17.38 Mn |
| Mar 31, 2018 | 17.38 Mn |
| Dec 31, 2017 | 8.47 Mn |
| Sep 30, 2017 | 5.32 Mn |
| Jun 30, 2017 | 10.92 Mn |
| Mar 31, 2017 | 27.45 Mn |
| Dec 31, 2016 | 29.69 Mn |
| Sep 30, 2016 | 20.68 Mn |
| Jun 30, 2016 | 17.13 Mn |
| Mar 31, 2016 | 18.67 Mn |
| Dec 31, 2015 | 20.23 Mn |
| Sep 30, 2015 | 7.43 Mn |
| Jun 30, 2015 | 14.10 Mn |
| Mar 31, 2015 | 9.32 Mn |
| Dec 31, 2014 | 12.41 Mn |
| Sep 30, 2014 | 967,000.00 |
| Jun 30, 2014 | 1.31 Mn |
| Mar 31, 2014 | 7.72 Mn |
| Dec 31, 2013 | 8.08 Mn |
| Sep 30, 2013 | 8.13 Mn |
| Jun 30, 2013 | 6.73 Mn |
| Mar 31, 2013 | 7.07 Mn |
| Dec 31, 2012 | 7.53 Mn |
| Mar 31, 2012 | 8.20 Mn |
| Dec 31, 2011 | 9.40 Mn |
| Sep 30, 2011 | 7.90 Mn |
| Jun 30, 2011 | 10.98 Mn |
| Dec 31, 2010 | 1.31 Mn |